Skip to main content

PULMOTREE

Acquired

PULMOTREE provides the Kolibri Mesh-Nebulizer, a connected aerosol therapy platform that combines highly efficient drug delivery with adherence monitoring and inhalation technique analysis to reduce clinical risks. The system integrates a Key & Lock technology for drug-device combination protection and a companion app for data-driven patient support, serving pharmaceutical partners and healthcare providers in pulmonary care.

Traction 4/10
Munich, Germany · HQ
Founded 2018132K+ followers
  • Medical Devices
  • Healthcare Technology
  • Hardware
Updated 6 days ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional aerosol therapy often lacks precise monitoring of patient adherence and inhalation technique, leading to suboptimal drug delivery and increased clinical risks. This can result in reduced treatment efficacy and challenges in managing respiratory conditions that require consistent, targeted pulmonary drug deposition.

Solution

PULMOTREE provides the Kolibri Mesh-Nebulizer, an advanced aerosol therapy platform designed for highly efficient drug delivery. The system incorporates adherence monitoring and inhalation technique analysis to reduce clinical risks and maximize support for both patients and caregivers. By integrating a connected ecosystem, the platform enables data-driven insights into the inhalation process, supporting more effective treatment regimens. The company's innovative Key & Lock technology adds a layer of value and protection for drug-device combinations, ensuring exclusivity and safety. PULMOTREE's approach is built on partnership, working collaboratively with pharmaceutical and medical technology partners to advance the field of inhalation therapy.

Target Audience

Primary customers are pharmaceutical and medical technology companies developing inhaled drug therapies, as well as healthcare providers and researchers focused on pulmonary drug delivery and respiratory care.

Features

  • Kolibri Mesh-Nebulizer for efficient and precise aerosol generation
  • Adherence monitoring to track patient usage and improve treatment consistency
  • Inhalation technique analysis to optimize drug deposition in the lungs
  • Innovative Key & Lock technology for value and protection of drug-device combinations
  • Connect Eco-System and Connect App for data integration and patient support
  • Flamingo Spirometer for respiratory function measurement
This profile is AI-generated and may contain inaccuracies.